Literature DB >> 3486925

Failure of therapy in pseudomonas endocarditis: selection of resistant mutants.

V E Jimenez-Lucho, L D Saravolatz, A A Medeiros, D Pohlod.   

Abstract

Despite optimal use of available antibacterial agents, endocarditis due to Pseudomonas aeruginosa is commonly associated with poor response to medical treatment. Two patients are described in whom emergence of resistance to beta-lactam antibiotics was associated with clinical failure. A subpopulation of resistant mutants (10(-7)) was found within the initial, apparently sensitive population of bacteria. These resistant mutants were similar to posttherapy isolates in their increased production of beta-lactamase and in their identical pattern of resistance to beta-lactam antibiotics. Moreover, the only beta-lactamase produced was type Id, and this enhanced production proved to be constitutive. A relatively large inoculum (10(6) colony-forming units/g of tissue) of bacteria was found postoperatively in the heart valves of both patients. The failure to respond is postulated to be due to the selection of these producers of high levels of beta-lactamase in a large bacterial inoculum.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486925     DOI: 10.1093/infdis/154.1.64

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

1.  Review of the pharmacology, pharmacokinetics, and clinical use of cephalosporins.

Authors:  D Kalman; S L Barriere
Journal:  Tex Heart Inst J       Date:  1990

Review 2.  Antimicrobial agent therapy for Pseudomonas aeruginosa.

Authors:  J A Korvick; V L Yu
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

3.  Infective Endocarditis of the Aortic Valve caused by Pseudomonas aeruginosa and Treated Medically in a Patient on Haemodialysis.

Authors:  Kowthar S Hassan; Dawood Al-Riyami
Journal:  Sultan Qaboos Univ Med J       Date:  2012-02-07

Review 4.  Selective IgG subclass deficiency: quantification and clinical relevance.

Authors:  R Jefferis; D S Kumararatne
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

5.  Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model.

Authors:  Y Q Xiong; J Caillon; M F Kergueris; H Drugeon; D Baron; G Potel; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

Review 6.  Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Authors:  Philip D Lister; Daniel J Wolter; Nancy D Hanson
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

7.  Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis.

Authors:  A S Bayer; L Hirano; J Yih
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

8.  Bactericidal interactions of a beta-lactam and beta-lactamase inhibitors in experimental Pseudomonas aeruginosa endocarditis caused by a constitutive overproducer of type Id beta-lactamase.

Authors:  A S Bayer; M Selecky; K Babel; L Hirano; J Yih; T R Parr
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.